China Life Private Equity

Hanbang Technology integrates R&D, production, and trade, with liquid chromatography products as the core.

METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

SinoTau is a total solution provider specializing in generic drugs and innovative drugs. They provide cardiovascular fields, neurodegeneration fields, and tumor fields. The company specializes in the early development of antibody biopharmaceuticals and is researching a variety of medicines for use in treating cancers, neurological illnesses, and autoimmune diseases.

GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company that focuses on the research and development of innovative Bio-therapeutics. GeneQuantum was founded in August 2013 at Suzhou Industrial Park, and has built-up a world-class bio-conjugation technology platform, focusing on developing series of next generation anti-tumor Antibody-Drug-Conjugates (ADCs) with best-in-class potential. Securing this round of financing will significantly promote the development of current ADC candidates towards IND filling in both US and China, meanwhile further expanding the company's product pipeline.

OPM Biosciences is a Shanghai-based biotech company, engaged in development and production of serum-free medium for culturing animal cells.

Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

Wanka Online is a technology company that provides android based content distribution services for marketers seeking mobile advertising, online video distribution, and game co-publishing services. They also provide technical support services. Wanka Online connects businesses from a variety of industries to China's hundreds of millions of Android-based smartphone users. Wanka Online's DAPG platform is made up of a number of interconnected technological platforms that are powered by cutting-edge technologies such as data mining, data analytics, and scenario analysis. It enables our marketers to precisely and efficiently target Android-based smartphone users and delivers personalized, real-time, and scenario-based content via smartphone manufacturers' self-owned mobile apps and user interfaces.

Asia Bioenergy Technologies Berhad (ABT) is a Malaysia-based technology incubation and investment holding company. The Company operates in four business segments: technology incubation, which comprises the main business segments; biofuel related products, which includes the sale of compounds for use in biofuel processes; information technology, which is engaged in the provision of information technology training and related services and equipment and corporate services, and biotechnology products, which is engaged in the provision of biotechnology products and services.